Stuart Grant Turville

Associate Professor Stuart Grant Turville is a leading researcher at the Kirby Institute, University of New South Wales, specializing in molecular virology, immunology, and gene therapy applications for infectious diseases. His work bridges basic science with translational solutions, particularly for HIV and emerging pandemics like COVID-19 and monkeypox. He has contributed to over 86 primary journal articles with 5340 citations and secured significant grants for pandemic response and HIV cure research.

Research Highlights:

• Focus on HIV pathogenesis, transmission, and viral gene therapies.
• Key role in SARS-CoV-2 variant surveillance and therapeutic development during the pandemic.
• Collaborations with national institutions like Lifeblood and CSL Behring.

Grants:

• STRIVE Grant (MRFF2015313) – $1.99M (2023–2028)
• CIRCUIT Study (MRFF2015313) – $2.81M (2022–2027)
• SARS-CoV-2 immunity study (MRFF2005760) – $0.99M (2021–2023)
• Hyperimmune globulin for COVID-19 (MRFF2001684) – $2.07M (2020–2022)
• HIV gene therapy (NHMRC Ideas Grant) – $0.84M (2019–2023)

His research leverages molecular medicine platforms for real-time pandemic surveillance and therapeutic development, emphasizing interdisciplinary collaboration and public health impact.